Iwicki Mark T

Director at Inhibikase Therapeutics, Inc. · on record since Feb 25, 2025
Chief Executive Officer at Inhibikase Therapeutics, Inc. · on record since Feb 25, 2025
EVP & Chief Commercial Officer at Sunovion Pharmaceuticals Inc. · on record since Oct 22, 2007
Director at Q32 Bio Inc. · on record since Jun 16, 2026
Director at Aimmune Therapeutics, Inc. · on record since Aug 11, 2015
Director at Pulmatrix, Inc. · on record since Dec 9, 2015
Director at KALA BIO, Inc. · on record since Jul 21, 2017
10% owner at KALA BIO, Inc. · on record since Jul 21, 2017
Director at Akero Therapeutics, Inc. · on record since Jun 19, 2019
Director at Merus N.V. · on record since Jan 2, 2020
Director at Jade Biosciences, Inc. · on record since Jun 29, 2021
CHIEF EXECUTIVE OFFICER at KALA BIO, Inc. · on record since Jul 21, 2017
Director at Third Harmonic Bio, Inc. · on record since Sep 14, 2022

Insider trading activity of Iwicki Mark T

Transactions on record: 148; since Oct 22, 2007

Open-market buys: 3; $620K

Open-market sells: 14; $569.6K

Companies traded: 10; last filing Jul 21, 2026

Figures computed from official regulatory filings — .

Companies where Iwicki Mark T has traded

Q32 Bio Inc.10 tx · Jul 21, 2026
Inhibikase Therapeutics, Inc.5 tx · Jan 7, 2026
Merus N.V.20 tx · $7.7M · Dec 12, 2025
15 tx · Dec 9, 2025
44 tx · $569.6K · Oct 24, 2025
9 tx · Aug 14, 2025
6 tx · Jun 7, 2024
10 tx · Feb 1, 2021
19 tx · $7.5M · Oct 14, 2020
10 tx · $12.1M · Oct 22, 2009

Track record of Iwicki Mark T

Statistical track record

Free account

Open-market buys: 5

Last buy: Apr 3, 2018

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Iwicki Mark T

Co-insiders of Iwicki Mark T

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Q32 Bio Inc.Listing on record	Jul 21, 2026	AwardD (derivative)	10,826	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Q32 Bio Inc.Listing on record	Jun 16, 2026	AwardD (derivative)	9,810	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Inhibikase Therapeutics, Inc.Listing on record	Jan 7, 2026	AwardD (derivative)	4,982,706	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-14,414	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-8,631	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-6,120	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-16,604	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-4,983	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-8,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-5,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-8,844	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-13,193	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	Other	-73,576	97.00 USD	$7.1M	Unusual size	SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-26,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	Other	-9,398	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-70,587	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-76,227	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-13,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-13,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-11,493	—	n/a (No price was disclosed in the filing)		SEC
Q32 Bio Inc.Listing on record	Oct 27, 2025	AwardD (derivative)	53,521	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
KALA BIO, Inc.Listing on record	Oct 24, 2025	Sell	-154,894	0.81 USD	$125.5K	Unusual size	SEC
Third Harmonic Bio, Inc.Listing unverified	Aug 14, 2025	Other	-128,631	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Q32 Bio Inc.Listing on record	Jul 21, 2026	AwardD (derivative)	10,826	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Q32 Bio Inc.Listing on record	Jun 16, 2026	AwardD (derivative)	9,810	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Inhibikase Therapeutics, Inc.Listing on record	Jan 7, 2026	AwardD (derivative)	4,982,706	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-14,414	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-8,631	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-6,120	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-16,604	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-4,983	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-8,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-5,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-8,844	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	OtherD (derivative)	-13,193	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Merus N.V.Listing unverified	Dec 12, 2025	Other	-73,576	97.00 USD	$7.1M	Unusual size	SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-26,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	Other	-9,398	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-70,587	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-76,227	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-13,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-13,000	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Dec 9, 2025	OtherD (derivative)	-11,493	—	n/a (No price was disclosed in the filing)		SEC
Q32 Bio Inc.Listing on record	Oct 27, 2025	AwardD (derivative)	53,521	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
KALA BIO, Inc.Listing on record	Oct 24, 2025	Sell	-154,894	0.81 USD	$125.5K	Unusual size	SEC
Third Harmonic Bio, Inc.Listing unverified	Aug 14, 2025	Other	-128,631	—	n/a (No price was disclosed in the filing)		SEC